ArticleLeukemia2013

F14512, a polyamine-vectorized anti-cancer drug, currently in clinical trials exhibits a marked preclinical anti-leukemic activity.

A Kruczynski et al.PubMed ↗Publisher ↗

No numbers read from the abstract.